A Presentation Summary of the Latest COVID-19 and Type 2 Diabetes Science
May 14, 2020
The science on COVID-19 and type 2 diabetes continues to evolve rapidly. If you haven’t been able to keep up to date on our latest COVID-19 coverage, don’t fret. Virta Medical Director Dr. Sarah Hallberg summarizes some key topics in this presentation, including:
- Why it is difficult to get a definitive scientific understanding of COVID-19
- Type 2 diabetes as a risk factor for COVID-19, including a systematic review and meta-analysis
- Obesity as a risk factor for COVID-19, including an examination of cases of requiring invasive mechanical ventilation
- Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes
- The latest on outcomes associated with use of Angiotensin-converting Enzyme Inhibitors (ACEI) and Angiotensin II Receptor Blockers (ARB)
Some of this is technical content, and if you have questions, we'd love to hear from you.
Get the latest Virta updates in your inbox
Subscribe to our blog to get Virta updates, delivered directly to you.
Subscribe